Literature DB >> 6125284

Metachromatic leukodystrophy caused by a partial cerebroside sulfatase.

H Kihara, A L Fluharty, J S O'Brien, C H Fish.   

Abstract

A patient with neuropathy and myopathy since infancy but whose neuropathy had been stable for a number of years showed a profound deficiency of arylsulfatase A in leukocytes and urine. Urine contained material that stained metachromatically and cochromatographed with cerebroside sulfate. In contrast, cultured fibroblasts contained about 10-20% of normal arylsulfatase A with properties identical to properties of normal fibroblast enzyme, except that it showed no cerebroside sulfatase activity. Growing fibroblasts in the cerebroside sulfate loading test had an attenuated rate of sulfatide hydrolysis. A re-examination of the cerebroside sulfatase reaction revealed that while only limited hydrolysis occurred with low concentrations of taurodeoxycholate or cholate (type I activation), significant hydrolysis of the natural substrate did take place with high concentrations of cholate (type II activation). This suggests that there is a partial cerebroside sulfatase defect in this atypical form of metachromatic leukodystrophy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125284     DOI: 10.1111/j.1399-0004.1982.tb00759.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Low arylsulphatase A activity and choreoathetotic syndrome in three siblings: differentiation of pseudodeficiency from metachromatic leukodystrophy.

Authors:  J Kappler; R W Watts; E Conzelmann; D A Gibbs; P Propping; V Gieselmann
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

2.  The influence of low arylsulfatase A activity on neuropsychiatric morbidity: a large-scale screening in patients.

Authors:  P Propping; W Friedl; M Huschka; K H Schlör; F Reimer; M Lee-Vaupel; E Conzelmann; K Sandhoff
Journal:  Hum Genet       Date:  1986-11       Impact factor: 4.132

3.  Identification of a missense ARSA mutation in metachromatic leukodystrophy and its potential pathogenic mechanism.

Authors:  Liyuan Guo; Bo Jin; Yidan Zhang; Jing Wang
Journal:  Mol Genet Genomic Med       Date:  2020-09-01       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.